![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, April 14, 2023 4:08:26 AM
(from an interview with german weekly magazine "Die Bunte", may 2022 - through google translator)
We've finally made a breakthrough in Parkinson's
Q: How is the brain destroyed in Alzheimer's and Parkinson's?
A: All neurodegenerative diseases - whether Alzheimer's, Parkinson, ALS – have one thing in common: a different protein that previously has a normal function in the body,
begins for reasons we don't even know yet, to change its structure. It becomes pathological, forms clumps and kills the nerve cells in the brain.
We want to fight these proteins. But that is great for two reasons difficult: The therapies first have to go all the way to be brought to the brain. And then they are only allowed to attack the sick protein, not the healthy one.
Q: Where do you stand in Parkinson's research?
A: We've had a groundbreaking breakthrough this year.
We have developed an imaging method that early diagnosis of Parkinson's disease could. What has been known about Alzheimer's for 20 years was for Parkinson's not yet possible. We can now to the first take a look inside the brains of Parkinson's patients and make the pathological deposits visible. That is a incredibly important first step in diagnosis and treatment development of Parkinson's disease. It's a revolution from my point of view.
Q: Why?
A: This is the only way we can make early and precise diagnoses.
When the first symptoms of Alzheimer's appear, that's it destroys up to 70 percent of nerve cells. It already exists today a blood test with a probability of more than 90 percent ability to predict whether one will fall ill. I am convinced that at some point this will also be possible with Parkinson's will be. And I also firmly believe that against both Diseases it will eventually have vaccinations.
![Bullish](/static/images/ih2-bull.png)
Recent ACIU News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/21/2024 12:00:53 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/16/2024 06:23:08 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/13/2024 10:16:36 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/13/2024 10:00:15 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/09/2024 09:30:11 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/22/2024 12:53:22 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/03/2024 09:19:30 PM
- AC Immune Progress Update on Phase 2 Active Immunotherapy Clinical Pipeline for Alzheimer's and Parkinson diseases • GlobeNewswire Inc. • 01/03/2024 01:10:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/28/2023 09:22:59 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/19/2023 01:53:14 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/15/2023 10:27:42 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/15/2023 09:31:21 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/15/2023 12:27:03 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/11/2023 09:18:18 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/06/2023 09:37:10 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/01/2023 12:13:49 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/03/2023 11:30:08 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/22/2023 08:17:36 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/21/2023 08:23:29 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/17/2023 08:15:57 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/09/2023 08:16:15 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/08/2023 08:20:05 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/04/2023 11:30:36 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/26/2023 11:17:17 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/24/2023 08:22:33 PM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM